Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Saeko Masuda"'
Autor:
Tadahiro Yonezu, Shoichi Ito, Kazuaki Kanai, Saeko Masuda, Kazumoto Shibuya, Satoshi Kuwabara
Publikováno v:
Case Reports in Neurology, Vol 4, Iss 3, Pp 202-206 (2012)
Adult-onset Alexander disease (AOAD) has been increasingly recognized since the identification of the glial fibrillary acidic protein gene mutation in 2001. We report on a 56-year-old man who was genetically confirmed as AOAD with the glial fibrillar
Externí odkaz:
https://doaj.org/article/88b639da19a749fdbefd2d88d78206d0
Publikováno v:
Case Reports in Medicine, Vol 2011 (2011)
Lidocaine unmasks silent symptoms and eases neuropathic pain in multiple sclerosis patients; however, the effects of lidocaine in neuromyelitis optica have never been reported. We describe the case of a 59-year-old Japanese woman with neuromyelitis o
Externí odkaz:
https://doaj.org/article/2fcc7bada5814c94b383a40bbb8e0229
Publikováno v:
Clinical and Experimental Neuroimmunology. 6:299-303
Autoimmune polyendocrine syndromes (APS), a group of autoimmune-mediated multiple endocrine gland failure, type 3 is composed of autoimmune thyroid disease with endocrinopathy, including type 1 diabetes mellitus (DM), other than adrenal insufficiency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f7943efe0823c378402cffdf840745f
https://doi.org/10.1111/cen3.12232
https://doi.org/10.1111/cen3.12232
Autor:
Tomohiko Uchida, Akiyuki Uzawa, Masahiro Mori, Saeko Masuda, Hiroki Masuda, Satoshi Kuwabara, Mayumi Muto
Publikováno v:
Multiple Sclerosis Journal. 21:1204-1208
Good-outcome neuromyelitis optica (NMO) is defined as an Expanded Disability Status Scale (EDSS) score of ≤3.0 at 10 years after onset. The clinical courses of 80 consecutive patients with NMO were analyzed to identify the frequency and features of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0add65908d3c73d53d71f89871a858ac
https://doi.org/10.1177/1352458514560927
https://doi.org/10.1177/1352458514560927
Publikováno v:
Clinical and Experimental Neuroimmunology. 4:206-209
Upbeat nystagmus (UBN) is relatively rare. Little is known about UBN in acute central nervous system inflammatory disorders, including multiple sclerosis (MS), neuromyelitis optica (NMO) and related disorders. We investigated two patients with MS, on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14dad176491894c4fe999e8ecf41d7ec
https://doi.org/10.1111/cen3.12013
https://doi.org/10.1111/cen3.12013
Publikováno v:
Clinical and Experimental Immunology. 172:37-43
Summary High mobility group box 1 (HMGB1) is an established inflammatory mediator when released from cells. Recent studies have implicated extracellular HMGB1 in the pathogenesis of various autoimmune diseases. The objective of this study was to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e152b8c21addb82fcf3a973f07e7ffdf
https://doi.org/10.1111/cei.12036
https://doi.org/10.1111/cei.12036
Autor:
Kazuaki Kanai, Tadahiro Yonezu, Kazumoto Shibuya, Shoichi Ito, Satoshi Kuwabara, Saeko Masuda
Publikováno v:
Case Reports in Neurology
Case Reports in Neurology, Vol 4, Iss 3, Pp 202-206 (2012)
Case Reports in Neurology, Vol 4, Iss 3, Pp 202-206 (2012)
Adult-onset Alexander disease (AOAD) has been increasingly recognized since the identification of the glial fibrillary acidic protein gene mutation in 2001. We report on a 56-year-old man who was genetically confirmed as AOAD with the glial fibrillar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854f84c95106f07143273641e7c62298
http://europepmc.org/articles/PMC3506048
http://europepmc.org/articles/PMC3506048
Autor:
Sonoko Misawa, Nobusada Funabashi, Yukari Sekiguchi, Masae Uehara, Satoshi Kuwabara, Yoshio Kobayashi, Seitaro Nomura, Michiko Daimon, Saeko Masuda, Issei Komuro, Hideyuki Miyaiuchi
Publikováno v:
International Journal of Cardiology. 150:213-216
Seitaro Nomura , Nobusada Funabashi ⁎, Yukari Sekiguchi , Saeko Masuda , Satoshi Kuwabara , Sonoko Misawa , Michiko Daimon , Masae Uehara , Hideyuki Miyaiuchi , Issei Komuro , Yoshio Kobayashi a a Department of Cardiovascular Science and Medicine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e05032a5a68af62f283aab293bbf017a
https://doi.org/10.1016/j.ijcard.2011.05.009
https://doi.org/10.1016/j.ijcard.2011.05.009
Publikováno v:
European Journal of Neurology. 17:672-676
Results: The proportion of patients with more than 50% increase in the ARR after IFNB-1b treatment was much higher in NMO than in MS (P = 0.046). ARR was significantly lower in patients with MS after IFNB-1b administration than before (P = 0.015), bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c261dfba6f0cf86dc0a26978b1d84197
https://doi.org/10.1111/j.1468-1331.2009.02897.x
https://doi.org/10.1111/j.1468-1331.2009.02897.x
Autor:
Shoichi Ito, Fumio Nomura, Setsu Sawai, Saeko Masuda, Akiyuki Uzawa, Tomohiko Uchida, Satoshi Kuwabara, Mayumi Muto, Masahiro Mori
Publikováno v:
Clinica Chimica Acta. 421:181-183
The current 2006 neuromyelitis optica (NMO) criteria is useful for diagnosing NMO, however this criteria seemed to be insufficient at early stage of NMO. Hence, the development of diagnostic marker besides anti-aquaporin 4 antibody at early stage of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8cec2962002e620393da7c7dc9f5d6
https://doi.org/10.1016/j.cca.2013.03.020
https://doi.org/10.1016/j.cca.2013.03.020